Product Images Livdelzi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Livdelzi NDC 61958-3301 by Gilead Sciences, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - seladelpar 01

Chemical Structure - seladelpar 01

Figure 1 - seladelpar 02

Figure 1 - seladelpar 02

This appears to be a chart or graph with data related to ALP (Alkaline phosphatase) levels over a 12-month period for a placebo group (N=65) and a group taking LIVDELZI 10 mg (N=128). The data seems to show measurements at different time points ranging from 0 to 8 months, with values indicated on the y-axis from 0 to 350.*

PRINCIPAL DISPLAY PANEL - 10 mg Capsule Bottle Label - seladelpar 03

PRINCIPAL DISPLAY PANEL - 10 mg Capsule Bottle Label - seladelpar 03

The text has provided information about a medication named seladelpar, in capsule form. Each capsule contains less than 10mg of seladelpar, which is equivalent to 14.1 mg of seladelpar lysine. The dosage information is not fully visible in the text, but it advises seeing Prescribin instructions. It also mentions storage instructions, such as keeping the capsules between 68°F - 77°F and avoiding temperature excursions beyond 59°F - 86°F. The text includes a caution to keep the medication out of reach of children. This product is intended for oral use only. The medication is distributed by Gilead Sciences, Inc. located in Foster City, CA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.